ADIL 주가 차트
ADIL 재무
Adial Pharmaceuticals Inc
$2.08
-9.56%
$-0.21
종가: May 22, 16:00:00 GMT-4
$2.05
-1.44%
$-0.03
애프터마켓: May 22, 20:00:00 GMT-4
뒤로
Adial Pharmaceuticals Inc (ADIL) 재무
주요 통계
이전 종가
$2.3
시가
$2.26
일일 범위
$2 - $2.36
52주 범위
$1.38 - $440.66
거래량
144.6K
평균 거래량
64.2K
배당수익률
--
EPS(TTM)
-16.98
시가총액
$2.9M
ADIL란 무엇인가요?
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. The company is headquartered in Charlottesville, Virginia and currently employs 5 full-time employees. The company went IPO on 2018-07-27. The firm is focused on the development of therapies for the treatment and prevention of addiction and related disorders. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients and was recently investigated in the Company’s ONWARD pivotal Phase III clinical trial for the potential treatment of AUD in subjects with certain target genotypes identified using the Company’s proprietary companion diagnostic genetic test. AD04 is also used for the treatment of other addictive disorders, such as Opioid Use Disorder, obesity, smoking, and other drug addictions. The Company’s wholly owned subsidiary is Purnovate, Inc.
